Altria Group has recently decreased its investment in the e-cigarette company Juul Labs by approximately 70%.
The US Food and Drug Administration's decision to expel Juul Labs from the US market is having a detrimental effect on the company's growth. In 2018, Altria Group purchased a portion of Juul Labs' equity for $12.8 billion, but its current value has dropped to just $450 million.
This article contains excerpts or reposts from third-party sources. Copyright belongs to the original media and author. If there is any infringement, please contact us to delete it. Any organization or individual who wishes to reproduce the content should contact the author and refrain from direct reproduction.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
